EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY-NC-SA 4.0

The use of antipsychotics in the treatment of catatonia: a systematic review

Maximilien Redon iD, Jordan Virolle iD, François Montastruc iD, Simon Taïb iD, Alexis Revet iD, Julien Da Costa iD, Etienne Very iD

European Psychiatry · 2025 · 68 (1)

DOI: 10.1192/j.eurpsy.2025.9 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift European Psychiatry, online erschienen am 24.03.2025. Verfasst von Maximilien Redon und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Psychotherapy and Art Therapy, Toulouse University Hospital, Toulouse, France. Hauptthemen laut MEDLINE: Antipsychotic Agents, Catatonia. Die Arbeit wurde bisher 16-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Catatonia in psychotic patients presents unique challenges. While antipsychotics are the cornerstone of schizophrenia treatment, their use in catatonic patients is sometimes discouraged for fear of worsening the signs. Reports on the successful use of second-generation antipsychotics have been published. We conducted a systematic review according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines to describe the outcomes of antipsychotic-treated catatonic events.

Methods

We searched Medline and Web of Science databases from 2000 to 2023 using search terms including “catatonia” and “antipsychotic agents” for all original peer-reviewed articles, including clinical trials, observational studies, and case-reports. We included antipsychotic-treated catatonic events and extracted data on patient characteristics, pharmacological context, agent involved, and treatment outcomes for each antipsychotic trial.

Results

After screening 6,219 records, 79 full-text articles were included. Among them, we identified 175 antipsychotic trials (in 110 patients). Only 41.1% of the patients benefited from a previous benzodiazepine trial. Antipsychotic use was considered beneficial in 60.0% of the trials, neutral in 29.1%, and harmful in 10.9%. Trials tended to be reported as beneficial for amisulpride, clozapine, and risperidone, equivocal for aripiprazole and olanzapine, and mostly detrimental for haloperidol and quetiapine. Psychotic disorders were the most common underlying etiology (65.8%).

Conclusions

Antipsychotics could be an option in the treatment of catatonia in psychotic patients. However, with few exceptions, we found non-beneficial outcomes with all second-generation antipsychotics in varying proportions in this largest review to date. Although olanzapine is widely used, it is associated with mitigated reported outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antipsychotic AgentsCatatoniaHumans

Stichwörter der Autor:innen

antipsychoticscatatoniaschizophreniasystematic reviewtherapeutics

Substanzen

Antipsychotic Agents

Autor:innen und Institutionen

  • Department of Psychiatry, Psychotherapy and Art Therapy, Toulouse University Hospital, Toulouse, France.
  • Department of Medical and Clinical Pharmacology, Centre for Pharmacovigilance and Pharmacoepidemiology, Toulouse University Hospital, Faculty of Medicine, Toulouse, France.
  • Team PEPSS "Pharmacologie En Population cohorteS et biobanqueS", Toulouse University Hospital, Toulouse, France.
  • EMEIS Group, Clinique Marigny, Saint-Loup-Cammas, France.
  • Department of Child and Adolescent Psychiatry, Toulouse University Hospital, Toulouse, France.
  • CERPOP, Toulouse University Inserm, Toulouse, France.

ORCID-Profile: Maximilien Redon, Jordan Virolle, François Montastruc, Simon Taïb, Alexis Revet, Julien Da Costa, Etienne Very

Zitieren

APA

Redon, M., Virolle, J., Montastruc, F., Taïb, S., Revet, A., Da Costa, J., & Very, E. (2025). The use of antipsychotics in the treatment of catatonia: a systematic review. European Psychiatry, 68(1). https://doi.org/10.1192/j.eurpsy.2025.9

Vancouver

Redon M, Virolle J, Montastruc F, Taïb S, Revet A, Da Costa J, et al. The use of antipsychotics in the treatment of catatonia: a systematic review. European Psychiatry. 2025;68(1). doi:10.1192/j.eurpsy.2025.9

BibTeX
@article{Redon2025,
  author = {Redon, Maximilien and Virolle, Jordan and Montastruc, François and Taïb, Simon and Revet, Alexis and Da Costa, Julien and Very, Etienne},
  title = {The use of antipsychotics in the treatment of catatonia: a systematic review},
  journal = {European Psychiatry},
  year = {2025},
  volume = {68},
  number = {1},
  doi = {10.1192/j.eurpsy.2025.9}
}
Kostenlos starten →